CNS Pharmaceuticals announces 1-for-50 reverse stock split effective Feb 21, 2025

CNS Pharmaceuticals, Inc.

Reverse stock split at 1-for-50 ratio effective Feb 21, 2025; shares outstanding reduced from ~136.93M to ~2.74M.
Split intended to increase per-share price to meet Nasdaq minimum bid price listing requirement.
No fractional shares; stockholders receive cash in lieu of fractional shares based on closing price on effective date.
Trading symbol remains "CNSP"; new CUSIP 18978H409; par value unchanged at $0.001.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.